Lower adiposity does not protect beta-2 syntrophin null mice from hepatic steatosis and inflammation in experimental non-alcoholic steatohepatitis.
Mice
Animals
Non-alcoholic Fatty Liver Disease
/ genetics
Adiposity
Cholesterol Esters
/ metabolism
Liver
/ metabolism
Inflammation
/ metabolism
Obesity
/ metabolism
Mice, Knockout
Fatty Acids
/ metabolism
Choline
/ metabolism
Methionine
Fatty Acid Synthases
Mice, Inbred C57BL
Disease Models, Animal
Bile acids
Cholesterol
Fat mass
Non-alcoholic steatohepatitis
Phospholipids
Journal
Gene
ISSN: 1879-0038
Titre abrégé: Gene
Pays: Netherlands
ID NLM: 7706761
Informations de publication
Date de publication:
05 Apr 2023
05 Apr 2023
Historique:
received:
17
06
2022
revised:
21
12
2022
accepted:
13
01
2023
pubmed:
22
1
2023
medline:
15
2
2023
entrez:
21
1
2023
Statut:
ppublish
Résumé
Visceral adiposity is strongly associated with liver steatosis, which predisposes to the development of non-alcoholic steatohepatitis (NASH). Mice with loss of the molecular adapter protein beta-2 syntrophin (SNTB2) have greatly reduced intra-abdominal fat mass. Hepatic expression of proteins with a role in fatty acid metabolism such as fatty acid synthase was nevertheless normal. This was also the case for proteins regulating cholesterol synthesis and uptake. Yet, a slight induction of hepatic cholesterol was noticed in the mutant mice. When mice were fed a methionine choline deficient (MCD) diet to induce NASH, liver cholesteryl ester content was induced in the wild type but not the mutant mice. Serum cholesterol of the mice fed a MCD diet declined and this was significant for the SNTB2 null mice. Though the mutant mice lost less fat mass than the wild type animals, hepatic triglyceride levels were similar between the groups. Proteins involved in fatty acid or cholesterol metabolism such as fatty acid synthase, apolipoprotein E and low-density lipoprotein receptor did not differ between the genotypes. Hepatic oxidative stress and liver inflammation of mutant and wild type mice were comparable. Mutant mice had lower hepatic levels of secondary bile acids and higher cholesterol storage in epididymal fat, and this may partly prevent hepatic cholesterol deposition. In summary, the current study shows that SNTB2 null mice have low intra-abdominal fat mass and do not accumulate hepatic cholesteryl esters when fed a MCD diet. Nevertheless, the SNTB2 null mice develop a similar NASH pathology as wild type mice suggesting a minor role of intra-abdominal fat and liver cholesteryl esters in this model.
Identifiants
pubmed: 36681100
pii: S0378-1119(23)00050-1
doi: 10.1016/j.gene.2023.147209
pii:
doi:
Substances chimiques
Cholesterol Esters
0
syntrophin
0
Fatty Acids
0
Choline
N91BDP6H0X
Methionine
AE28F7PNPL
Fatty Acid Synthases
EC 2.3.1.85
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
147209Informations de copyright
Copyright © 2023 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: